BluGlass Limited (ASX: BLG), a global leader commercialising a breakthrough platform technology called Remote Plasma Chemical Vapour Deposition (RPCVD), has appointed Brad Siskavich to a full-time role as Vice President of Business Development. Mr Siskavich will join the Company to, amongst other things, lead the expansion of the BluGlass custom services business, EpiBlu Pty Ltd, and is based in the US. Brad Siskavich has more than 20 years’ experience in developing, marketing and commercialising new technologies in start-up and high-growth environments in the compound semiconductor, photovoltaic (solar), laser, photonics and opto-electronics industries. He has previously worked in senior research and business development roles at companies that include Emcore, Oxford Instruments and Masimo Semiconductor.

EpiBlu is the service arm and wholly-owned subsidiary of BluGlass and offers specialised custom epitaxy, foundry and characterisation services at its state-of-the-art facility in Sydney, Australia. EpiBlu will continue to expand its operations, providing both MOCVD and BluGlass’ unique low temperature RPCVD services. This revenue generating business also creates new opportunities to introduce the advantages of BluGlass’ proprietary technology RPCVD to customers at the cutting edge of the opto-electronics industry.

BluGlass Managing Director Giles Bourne said, “Appointing Brad is an exciting step for BluGlass and the EpiBlu team and represents a new commitment to building our custom service revenues. He brings significant industry expertise to BluGlass, with deep research and business development experience across the sector. His role has a global focus for the EpiBlu service business; and provides us with a dedicated resource based in the US to develop export markets there for our RPCVD technology.”

- Ends -

Featured Posts
Recent Posts
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square